Hydrofarm Holdings Group, Inc. SEC filings document the company’s hydroponics equipment and supplies business, public-company governance and capital structure. Form 8-K reports cover operating results, material agreements, credit arrangements, revolving-credit termination, forbearance matters, auditor changes, executive and board transitions, and Nasdaq continued-listing compliance notices.
Proxy filings describe director elections, board committee matters, executive compensation and equity-award disclosures. The filing record also addresses liquidity, stockholders’ equity, risk factors, financial reporting controls and the debt obligations tied to Hydrofarm’s role as a branded manufacturer and distributor serving controlled environment agriculture markets.
William Douglas Toler, Executive Chairman and director of Hydrofarm Holdings Group, Inc. (HYFM), reported a sale of common stock. On 08/18/2025 he disposed of 445 shares at $4.51 per share. Following the reported transaction he beneficially owned 226,861 shares. The filing notes 1,500 stock-settled restricted stock units were vested and shares were withheld to satisfy tax withholding; fractional amounts were rounded to the nearest whole share. The Form 4 was signed on 08/19/2025.
Kevin Patrick O'Brien, identified as Chief Financial Officer and a director of Hydrofarm Holdings Group, Inc. (HYFM), reported a transaction dated 08/18/2025 involving his company's common stock. The filing shows a disposition of 48 shares at $4.51 per share recorded under transaction code F, and after the transaction he beneficially owns 14,372 shares directly.
The form's explanation states these 48 shares were withheld to satisfy tax withholding on the vesting of 166 restricted stock units that settle one-for-one in common stock. The report was signed on 08/19/2025. No other purchases, sales, derivative transactions, or amendments are disclosed in this filing.
Mark S. Parker, President of Hydrofarm Holdings Group, Inc. (HYFM), reported a routine disposition of company common stock on 08/18/2025. The Form 4 shows 370 shares were disposed at a reported price of $4.51 per share. After the transaction, Mr. Parker beneficially owned 21,000 shares directly.
The filing explains the 370-share disposition resulted from shares withheld to satisfy tax withholding on the vesting of 834 stock-settled restricted stock units, which are settled 1-for-1 in common stock. The document is a standard Section 16 reporting of an insider tax-withholding disposition and does not disclose other transactions or changes in control.
B. John Lindeman, who is identified as Chief Executive Officer and a director of Hydrofarm Holdings Group, Inc. (HYFM), reported a transaction dated 08/18/2025 related to the vesting of restricted stock units. The filing shows 1,167 stock-settled RSUs vested and 496 shares were withheld$4.5156,683 common shares directly. The Form 4 was signed on 08/19/2025. The filing contains an explanatory note that fractional amounts were rounded to the nearest whole share.
Mark S. Parker, President of Hydrofarm Holdings Group, Inc. (HYFM), reported a routine withholding transaction related to the vesting of restricted stock units. On 08/11/2025 1,667 stock-settled restricted stock units vested and 771 shares were withheld to satisfy tax withholding obligations at an indicated price of $4.49 per share. After the withholding, Mr. Parker beneficially owns 21,370 shares of common stock. The transaction was reported on a Form 4 and reflects a direct, non-derivative change in ownership tied to RSU vesting rather than an open-market sale.
Erica Ackerman, listed as Chief Accounting Officer and Corporate Controller of Hydrofarm Holdings Group, Inc. (HYFM), reported a securities transaction dated 08/11/2025 involving the company’s common stock.
The filing discloses that 333 stock-settled restricted stock units (RSUs) vested and shares were withheld to satisfy the related tax withholding obligation. The withholding activity is shown at a per-share amount of $4.49. After the reported transaction the reporting person is shown as beneficially owning 8,227 shares of common stock directly. The RSUs may be settled 1-for-1 in common shares and fractional amounts were rounded.
Hydrofarm Holdings Group, Inc. reported continued revenue contraction and operating losses for the quarter. Net sales were $39.2 million for the three months ended June 30, 2025 (down 28.4% year-over-year) and $79.8 million for the six months ended June 30, 2025 (down 26.8% year-over-year). Gross profit fell to $2.8 million for the quarter and $9.7 million year-to-date. Net loss was $(16.9) million for the quarter and $(31.2) million for the six months; basic loss per share was $(3.63) and $(6.75), respectively.
The company completed a 1-for-10 reverse stock split effective February 12, 2025, and executed the 2024 IGE asset sale with proceeds that were partially reinvested and used to prepay the Term Loan. Management initiated a 2025 restructuring (Q2 charges of $3.3 million) to reduce product portfolio and footprint and expects annual cost savings in excess of $3.0 million; cash declined to $11.0 million from $26.1 million at year-end. Term Loan principal remains material at ~$111.6 million (net of discounts).
Hydrofarm Holdings Group, Inc. announced on August 12, 2025 that it issued a press release reporting its financial results for the quarter ended June 30, 2025 and provided an earnings presentation on its investor relations website. The press release is furnished as Exhibit 99.1 and the earnings presentation as Exhibit 99.2. Both exhibits are expressly furnished, not filed, and the filing states they are not subject to the liabilities of Section 18 of the Exchange Act.
The Form 8-K identifies the company as a Delaware corporation trading Common Stock (HYFM) on Nasdaq and is signed by Chief Executive Officer B. John Lindeman. The filing also incorporates the press release's Cautionary Note Regarding Forward-Looking Statements into its Regulation FD disclosure and directs investors to https://investors.hydrofarm.com/ for the presentation.